Sort
10,766 grants matching “checkpoint inhibitor”
Clinical Protocol and Data Management
$560,347Shaji Kunnathu Kumar · Mayo Clinic Rochester · P30 · FY2020 · CA
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
$560,034Elias Sayour · University Of Florida · R01 · FY2022 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$559,846Gerald V Denis · Boston University Medical Campus · R01 · FY2018 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$559,834David P Carbone · Ohio State University · R01 · FY2022 · CA
Project-003
$559,613Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2020 · CA
Investigation of overlap between mitotic and ferroptotic pathways using novel hybrid small molecule inhibitors.
$559,543William R Taylor · University Of Toledo · R15 · FY2025 · GM
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities
$559,473Adam Burgener · Case Western Reserve University · R01 · FY2022 · CA
Myct1 control of the angioimmune interface
$559,360Kyunghee Choi · Washington University · R01 · FY2023 · CA
Epigenetic regulation of T cell differentiation during infection
$559,331John Justin Milner · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
CD200R blockade for cancer immunotherapy
$559,062Sujit Basu · Ohio State University · R01 · FY2024 · CA
PAG is a novel target in immunotherapy
$558,683Adam Mor · Columbia University Health Sciences · R01 · FY2021 · AI
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$558,663Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$558,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2018 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$558,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2020 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$558,602Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer
$558,523Jianmin Zhang · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
Clinical Protocol and Data Management
$558,028Shaji Kunnathu Kumar · Mayo Clinic Rochester · P30 · FY2022 · CA
Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment
$557,992Yubin Miao · University Of Colorado Denver · R01 · FY2025 · CA
Clinical Protocol and Data Management
$557,904Grzegorz Stanislaw Nowakowski · Mayo Clinic Rochester · P30 · FY2023 · CA
Clinical Protocol and Data Management
$557,904Shaji Kunnathu Kumar · Mayo Clinic Rochester · P30 · FY2021 · CA
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$557,887Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2016 · CA
Project 1: Promoting Graft-versus-Tumor Effects in the Bone Marrow
$557,823Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2020 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2021 · CA